Novel lethal genetic constructs engineered into Agrobacterium to streamline plant transformation workflows, eliminate antibiotic use, and provide environmental biocontainment for safe field testing. Reduces tissue culture contamination costs and plant stress while improving transformation efficiency.
This technology addresses two persistent challenges in plant biotechnology: the contamination and resource burden associated with Agrobacterium-mediated plant transformation, and the environmental biosafety concerns of releasing engineered bacteria into field settings. By incorporating novel, constitutive, and non-leaky lethal genetic constructs into Agrobacterium, the system removes the need for antibiotic-based decontamination of tissue cultures while adding a built-in biocontainment layer that prevents environmental escape. The result is a faster, cheaper, and safer plant transformation workflow with potential to enable field-level testing of engineered crops.
The technology is at an early research and development stage. The lethal construct is currently being integrated into Agrobacterium to test genetic stringency. Future validation steps include confirming non-leakiness via fluorometric measurements across multiple strains, replacing fluorescent reporters with lethal gene cassettes, verifying lethality, and benchmarking transformation efficiency of the suicide-Agrobacterium strains against their original counterparts. Successful completion of these milestones would position the technology for pilot-scale plant transformation trials.
Penn State University is a comprehensive public land‑grant research university with a large multi‑campus footprint across Pennsylvania. Industry engages through a research and technology park adjacent to the flagship campus that houses corporate R&D, co‑located labs, and flexible collaboration space, as well as a statewide extension network that enables field testing, demonstration, and workforce reach. Integration with a major hospital system supports clinical translation, and an applied research laboratory fosters mission‑driven partnerships with government and industry sponsors. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, DoD, and NASA. A dedicated technology transfer office manages IP, licensing, and startup formation to accelerate commercialization.